38
Participants
Start Date
September 14, 2005
Primary Completion Date
February 11, 2010
Study Completion Date
March 19, 2026
Sorafenib Tosylate
Memorial Sloan Kettering Cancer Center, New York
University of Chicago Comprehensive Cancer Center, Chicago
Decatur Memorial Hospital, Decatur
Central Illinois Hematology Oncology Center, Springfield
City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento
National Cancer Institute (NCI)
NIH